Oncology Devices Market Set for Robust Expansion, with AI Innovations and Advancements in Radiation Therapy Techniques
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The global oncology devices market is exhibiting impressive growth, and a new research report available on our website is providing a comprehensive analysis of this dynamic industry. Rapid advancements, innovative technologies, and an increased prevalence of cancer have fueled a projected market size expansion from $128.46 billion in 2023 to an estimated $298.31 billion by 2028.
Experts have diligently compiled data reflecting the growing demand for oncology devices driven by the increase in cancer cases across the globe. The report articulates how the upsurge in cancer instances is leading to a higher need for precise and innovative treatments using state-of-the-art oncology devices.
Market Segmentation and Regional Analysis
Within the report, the reader will find segmented market data specifying key categories such as brachytherapy and endoscopic devices. Included are valuable insights into the uses of these devices within chemotherapy, hormone therapy, and other cancer treatments. Moreover, a geographical analysis highlights North America's position as the largest market, followed by Asia-Pacific’s significant growth potential.
Technology Advancements and Market Trends
The report sheds light on emerging trends in the market, including the integration of Artificial Intelligence (AI), digital health technologies, and early cancer detection methods. Furthermore, it highlights transformative developments in radiation therapy techniques and the utilization of liquid biopsies as diagnostic tools.
AI-powered decision support systems enhancing cancer treatment
Minimally invasive surgical techniques and biodegradable implants propelling market growth
AIROS 6 device aiding breast cancer patients with post-mastectomy lymphedema treatment
Impact of Healthcare Developments and Company Innovations on Market
In addition to covering the effects of an aging population and the global expansion of healthcare services on the market, the report also focuses on key company innovations. For example, it details the recent launch of the benchmark ultra plus system by leading healthcare companies. These advancements in the diagnostic and pathology laboratories are enhancing workflow efficiency, patient results, and environmental sustainability.
Strategic Acquisitions and Industry Investments
The research also delves into significant acquisitions like that of GE Healthcare's integration of Zionexa, a pioneer in biomarkers for oncology solutions, and the resulting implications for cancer treatment personalization.
Challenges and Future Market Projections
While highlighting the market's promising outlook, the report also addresses hurdles like the limited per capita healthcare expenditure in developing countries, which may restrain the market to some extent.
In conclusion, the oncology devices market research report is a thorough and authoritative source that presents an in-depth analysis of the industry. It serves as an invaluable tool for those within the medical device sector, healthcare providers, and stakeholders involved in cancer care and research.
For more details and insights, the full oncology devices market research report is available for review on our website, providing an extensive prognosis and strategic analysis of the future landscape of oncology devices in the global market.
A selection of companies mentioned in this report includes
Eckert & Ziegler BEBIG GmbH
Oncura Inc.
GE Healthcare
Medtronic plc
Varian Medical Systems Inc.
Elekta AB
Theragenics Corporation
Accuray Incorporated
Roche Diagnostics
IBA Group
Biogenex Laboratories
Becton Dickinson and Company
Siemens Healthineers
Philips Healthcare
Hologic Inc.
IBA AG
ViewRay Inc.
Canon Medical Systems Corporation
Brainlab
PerkinElmer
RaySearch Laboratories
Mevion Medical Systems
Vision RT
IsoRay
RefleXion Medical
Alpha Tau Medical
Nanobiotix
Mirada Medical Ltd.
Navidea Biopharmaceuticals Inc.
For more information about this report visit https://www.researchandmarkets.com/r/qjsgiq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
